{
  "pmcid": "12227832",
  "sha256": "691af6c6eedad1d9a10c528dc6fac5acf01e1f4d72c526f98853116c2bb470ae",
  "timestamp_utc": "2025-11-09T23:30:36.750149+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.032464857796665,
    "reading_ease": 29.394800588427614,
    "word_count": 266
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Tranexamic Acid in Reducing Blood Loss During Nephrectomy for Wilms Tumor in Children"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "This prospective, randomised controlled trial was conducted at a tertiary healthcare center in India."
      },
      "Participants": {
        "score": 2,
        "evidence": "Sixty children under 10 years with Wilms tumor scheduled for elective nephrectomy"
      },
      "Intervention": {
        "score": 2,
        "evidence": "TXA group (n=30) received 50 mg/kg TXA intravenously, followed by 5 mg/kg/h infusion; NS group (n=30) received an equivalent volume of normal saline."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates the efficacy of tranexamic acid (TXA) in reducing blood loss during this procedure in children."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was intraoperative blood loss, measured during surgery."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence with allocation concealment via sealed envelopes."
      },
      "Blinding": {
        "score": 2,
        "evidence": "Both patients and outcome assessors were blinded."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Sixty children under 10 years with Wilms tumor scheduled for elective nephrectomy were randomised into two groups"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The TXA group had significantly lower intraoperative blood loss (216.33 mL vs 306.33 mL; p=0.001) and PRBC transfusion volume (167.0 mL vs 199.8 mL; p=0.045)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported in either group during the intraoperative or immediate postoperative period."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: Clinical Trial Registry of India (No. 2024/09/073921)."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 18,
    "max_score": 25
  }
}